← Back
$COGT All transactions

Cogent Biosciences, Inc.

A

$ Value

$0

Shares

50,000

Price

$0

Filed

Dec 19

Insider

Name

Pinnow Cole

Title

Chief Commercial Officer

CIK

0002024135

Roles

Officer

Transaction Details

Transaction Date

2025-12-17

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

97,450

Footnotes

Award of Restricted Stock Units ("RSUs") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates. | Includes an aggregate of 1,602 shares of common stock acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on June 30, 2025. | Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the "2023 PSUs"). | Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs. | Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. | This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates.

Filing Info

Accession No.

0001193125-25-326774

Form Type

4

Issuer CIK

0001622229

Pinnow Cole's History

Date Ticker Type Value
2025-12-17 COGT A $0
2025-12-17 COGT A $0
2025-12-17 COGT F $3.7M
2025-12-17 COGT A $0

Other Insiders at COGT (90d)

Insider Bought Sold Last
Ferrante Karen Jean 2026-04-01
Fairmount Funds Management LLC $242.6M 2026-03-31